Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

197
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
197
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

465
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
465
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

639
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
639
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

155
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
155
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

518
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
518
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methods to build and maintain effective clinician-patient relationships for adults with disorders of gut-brain interaction (DGBI): a systematic review.

Journal of gastroenterology·2026
Same author

Being Overweight or Obese Contributes to a Deterioration of the Liver Function in Steatotic Liver Disease: A Long-term Follow-up of Health Check-up Participants.

Internal medicine (Tokyo, Japan)·2026
Same author

Association between hypertension and a high FIB-4 index in individuals with hepatic steatosis.

Internal medicine (Tokyo, Japan)·2026
Same author

Early Therapeutic Response Predicts Outcome in Chronic Constipation: A Multicenter Prospective Observational Study.

Gastroenterology research·2026
Same author

Therapeutic Potential of the Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet in Functional Dyspepsia: A Systematic Review.

Digestion·2026
Same author

The Actual Condition of Chronic Constipation in Real-World Clinical Settings and Its Impact on Various Aspects of Daily Life.

Digestive diseases (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 18, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K

Functional Dyspepsia: Current Understanding and Future Perspective.

Tadayuki Oshima1

  • 1Department of Gastroenterology, Okazaki City Medical Association Public Health Center, Okazaki, Japan.

Digestion
|August 20, 2023
PubMed
Summary

Functional dyspepsia (FD) involves complex gut-brain interactions and multiple causes like delayed gastric emptying and visceral hypersensitivity. Effective management requires personalized treatment strategies tailored to individual patient symptoms and therapeutic responses.

Keywords:
Delayed emptyingHypersensitivityMicroinflammation

More Related Videos

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.9K
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

625

Related Experiment Videos

Last Updated: Jul 18, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.9K
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

625

Area of Science:

  • Gastroenterology
  • Gut-brain interaction research

Background:

  • Functional dyspepsia (FD) is a prevalent gastrointestinal disorder causing chronic upper abdominal pain or discomfort.
  • FD is classified into postprandial distress syndrome (PDS) and epigastric pain syndrome based on symptom presentation.

Purpose of the Study:

  • To elucidate the multifactorial pathophysiology of functional dyspepsia.
  • To outline current and potential therapeutic approaches for FD management.

Main Methods:

  • Review of existing literature on FD pathophysiology and treatment.
  • Analysis of mechanisms including gastric emptying, accommodation, visceral sensitivity, and duodenal mucosa alterations.

Main Results:

  • Approximately 30% of FD patients exhibit delayed gastric emptying, though not consistently linked to symptoms.
  • Impaired gastric accommodation and visceral hypersensitivity are key contributors to FD symptoms, especially in PDS.
  • Duodenal mucosal changes, microbial dysbiosis, and psychological factors also play significant roles in FD pathogenesis.

Conclusions:

  • FD is a disorder of gut-brain interaction with diverse underlying mechanisms.
  • Individualized treatment plans are essential for effective FD management.
  • Further research is necessary to enhance understanding and develop novel therapies for FD.